Inventor
Matthew Stirling
Inventor
Boston, MA, US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes13%
C07CAcyclic or carbocyclic compounds13%
Y02PClimate change mitigation technologies in the production or processing of goods13%
PatentTitleYear
10,745,404Process for the synthesis of E1 activating enzyme inhibitors20209,850,214Inhibitors of NEDD8-activating enzyme20179,802,938'Sulfamoylating reagents'20178,933,225'Process for the synthesis of E1 activating enzyme inhibitors'20158,809,356'Inhibitors of NEDD8-activating enzyme'20147,935,694'Lactam compounds useful as protein kinase inhibitors'20117,459,448'Lactam compounds useful as protein kinase inhibitors'2008Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2008–2020Patents assigned to MILLENNIUM PHARM INC (7)· patent assignee history
2008–2020Based in Boston, MA, US· patent location history
2014–2015Patents assigned to STIRLING MATTHEW (2)· patent assignee history
2014–2017Based in Randolph, MA, US· patent location history
2015Patents assigned to ARMITAGE Ian (1)· patent assignee history
2015Patents assigned to ELLIOTT ERIC L (1)· patent assignee history
2015Patents assigned to LANGSTON MARIANNE (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MILLENNIUM PHARM INC | 7 | 2008–2020 |
| STIRLING MATTHEWself | 2 | 2014–2015 |
| ARMITAGE Ian | 1 | 2015 |
| ELLIOTT ERIC L | 1 | 2015 |
| LANGSTON MARIANNE | 1 | 2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Boston, Massachusetts, US | 5 | 2008–2020 |
| Randolph, Massachusetts, US | 2 | 2014–2017 |